New drug shows promise for Early-Stage muscle weakness disease

NCT ID NCT06909214

Recruiting now Disease control Sponsor: argenx Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 35 times

Summary

This study is testing a drug called efgartigimod in adults who have been diagnosed with generalized myasthenia gravis (gMG) within the past year. The goal is to see if the treatment can reduce muscle weakness and improve daily activities. Participants will receive the drug for 51 weeks, and researchers will track how many achieve minimal or no symptoms within the first 16 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEW ONSET GENERALIZED MYASTHENIA GRAVIS (GMG) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Baycare Medical Group
RECRUITING

St. Petersburg, Florida, 33705, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Center for Neurological Disorders - Greenfield
RECRUITING

Greenfield, Wisconsin, 53228-1321, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Central Texas Neurology Consultants - Elligo
RECRUITING

Round Rock, Texas, 78681, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Cleveland Clinic
RECRUITING

Cleveland, Ohio, 44195, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
EZR Research
RECRUITING

Boca Raton, Florida, 33486, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Emory Brain Health Center
RECRUITING

Atlanta, Georgia, 30329, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Erlanger Neuroscience Institute
RECRUITING

Chattanooga, Tennessee, 37403, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
HSHS Medical Group
RECRUITING

O'Fallon, Illinois, 62269, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Hawaii Pacific Neuroscience
RECRUITING

Honolulu, Hawaii, 96817, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Henry Ford Health System
RECRUITING

Detroit, Michigan, 48202, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Medsol Clinical Research Center Inc
RECRUITING

Port Charlotte, Florida, 33952, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Samir Macwan, M.D., Inc. (S corporation)
RECRUITING

Rancho Mirage, California, 92270, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
The Queen's Medical Center - West Oahu
RECRUITING

Honolulu, Hawaii, 96813, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
UMass Memorial Medical Center
RECRUITING

Worcester, Massachusetts, 01655, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
University of California Irvine
RECRUITING

Orange, Florida, 92868, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
University of California, San Diego - Altman Clinical and Translational Research Institute (ACTRI)
RECRUITING

La Jolla, California, 92037, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
University of Florida Jacksonville
RECRUITING

Jacksonville, Florida, 32209, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Visionary Investigators Network
RECRUITING

Miami, Florida, 33133, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

NEW ONSET GENERALIZED MYASTHENIA GRAVIS (GMG) NEW ONSET GENERALIZED MYASTHENIA GRAVIS (GMG)